The role of histone demethylases in cancer therapy

Abstract: Reversible histone methylation has emerged in the last few years as an important mechanism of epigenetic regulation. Histone methyltransferases and demethylases have been identified as contributing factors in the development of several diseases, especially cancer. Therefore, they have been postulated to be new drug targets with high therapeutic potential. Here, we review histone demethylases with a special focus on their potential role in oncology drug discovery. We present an overview over the different classes of enzymes, their biochemistry, selected data on their role in physiology and already available inhibitors. (C) 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
Molecular Oncology. 6 (2012), 683-703, DOI 10.1016/j.molonc.2012.07.004, issn: 1574-7891
IN COPYRIGHT http://rightsstatements.org/page/InC/1.0 rs

Schlagwort
Epigenetik
Histone
Lysin
Krebs
Onkologie

Ereignis
Veröffentlichung
(wo)
Freiburg
(wer)
Universität
(wann)
2012
Urheber

DOI
10.1016/j.molonc.2012.07.004
URN
urn:nbn:de:bsz:25-freidok-130145
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
25.03.2025, 13:43 MEZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.

Entstanden

  • 2012

Ähnliche Objekte (12)